Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report released on Thursday. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Performance

NASDAQ:RKDA opened at $3.89 on Thursday. The company has a market cap of $5.30 million, a PE ratio of -0.91 and a beta of 0.88. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $10.31. The stock has a 50-day simple moving average of $5.10 and a 200 day simple moving average of $4.04.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new stake in Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned approximately 0.90% of Arcadia Biosciences as of its most recent SEC filing. 17.73% of the stock is owned by institutional investors.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.